Methotrexate for rheumatoid arthritis
Relevant BNF section: 10.1.3
Treatment of patients with rheumatoid arthritis (RA) conventionally starts with an analgesic plus a non-steroidal anti-inflammatory drug (NSAID). Slow-acting antirheumatic drugs are being added at an increasingly early stage of the disease.1 When we reviewed slow-acting antirheumatics two years ago1 methotrexate had only recently been licensed in the UK for the treatment of RA. In the USA methotrexate is often preferred to traditional slow-acting antirheumatics such as gold, sulphasalazine and penicillamine. We examine the evidence.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Anaesthesia
-
Infections
-
Malignant disease and immunosuppression
-
Haematology (drugs and medicines)
-
Musculoskeletal and joint disorders
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
